Previous Article | Next Article 
Journal of Virology, November 1998, p. 9217-9223, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The 5' and 3' TAR Elements of Human Immunodeficiency Virus Exert
Effects at Several Points in the Virus Life Cycle
Atze T.
Das,
Bep
Klaver, and
Ben
Berkhout*
Department of Human Retrovirology, University
of Amsterdam, Academic Medical Center, Amsterdam, The Netherlands
Received 1 June 1998/Accepted 24 July 1998
 |
ABSTRACT |
The human immunodeficiency virus type 1 RNA genome contains a
terminal repeat (R) sequence that encodes the TAR hairpin motif, which
has been implicated in Tat-mediated activation of transcription. More
recently, a variety of other functions have been proposed for this
structured RNA element. To determine the replicative roles of the 5'
and 3' TAR hairpins, we analyzed multiple steps in the life cycle of
wild-type and mutant viruses. A structure-destabilizing mutation was
introduced in either the 5', the 3', or both TAR motifs of the proviral
genome. As expected, opening of the 5' TAR hairpin caused a
transcription defect. Because the level of protein expression was not
similarly reduced, the translation of this mRNA was improved. No effect
of the 3' hairpin on transcription and translation was measured.
Mutations of the 5' and 3' hairpin structures reduced the efficiency of
RNA packaging to similar extents, and RNA packaging was further reduced
in the 5' and 3' TAR double mutant. Upon infection of cells with these
virions, a reduced amount of reverse transcription products was
synthesized by the TAR mutant. However, no net reverse transcription
defect was observed after correction for the reduced level of virion RNA. This result was confirmed in in vitro reverse transcription assays. These data indicate that the 5' and 3' TAR motifs play important roles in several steps of the replication cycle, but these
structures have no significant effect on the mechanism of reverse
transcription.
 |
INTRODUCTION |
Retroviral RNA genomes contain a
sequence repeat (R) that forms the extreme 5' and 3' ends of the viral
transcripts. This terminal repeat of the genome of human
immunodeficiency virus type 1 (HIV-1) is 97 nucleotides in length and
contains important cis elements for several steps in viral
replication. The TAR RNA hairpin structure within R is important for
optimal transcription from the viral promoter in the long terminal
repeat (LTR). In particular, the upper part of the TAR structure has
been shown to be important for binding of the viral Tat transactivator
protein that triggers high-level expression through interaction with
the cellular transcription machinery (12, 25, 38, 59, 60). The R region also encodes sequences that are important for
polyadenylation of the viral transcripts (4, 18, 28).
Whereas the TAR element is functional primarily in the context of the
5' LTR promoter (41), the polyadenylation signals are used
exclusively within the 3' LTR context. A second structured motif is
encoded by the R region, the poly(A) hairpin (10), which is
also critical for efficient viral replication, probably at the level of
RNA packaging (24, 46). Retroviruses also use the terminal
repeat in the process of reverse transcription. This process is
initiated near the 5' end of the genome at the primer-binding site, and
a DNA copy of the 5' R region is synthesized (strong-stop minus-strand cDNA). Upon removal of the 5' R template strand by RNase H action of
reverse transcriptase (RT), this cDNA anneals to the 3' R region and
reverse transcription is resumed. It is currently unknown whether
specific sequence or structure motifs within R are required for
efficient strand transfer (13).
Although it is generally believed that the TAR element is a critical
transcription motif that mediates the Tat response, there have been
numerous reports of posttranscriptional effects exerted by this
element. A translational component of Tat/TAR-mediated activation of
gene expression has been reported initially (22). The 5' TAR
structure was also shown to interfere with mRNA translation in
Xenopus oocytes (16, 17) and in cell-free assays
(47, 53, 57), and this repression could be overcome by
addition of the Tat protein. Two mechanistic explanations have been
proposed for TAR-mediated repression of translation. First, the
5'-terminal TAR hairpin may inhibit translation in cis by
interfering with the binding of translation initiation factors or
ribosomes to the mRNA cap structure (47). Second, TAR may
activate the double-stranded RNA-dependent kinase PKR (26, 50,
53). The activated form of this kinase phosphorylates and thereby
inactivates the translation initiation factor eIF-2, causing inhibition
of translation in trans.
Besides a role of TAR in viral transcription and translation, recent
studies have suggested additional functions for the TAR motif, in
particular the base-paired stem region, in the viral life cycle
(42, 49). Detailed studies indicated that TAR is involved
both in packaging of the RNA into viral particles (46) and
in reverse transcription (32). Although the exact function of TAR in packaging of the viral genome remains to be determined, it is
possible that TAR is part of the packaging signal that is recognized by
the viral Gag protein during virion assembly. The packaging function of
TAR was shown to be independent of the Tat protein (46). The
exact role of TAR in reverse transcription is also presently unknown,
but TAR could affect this mechanism at several levels. The TAR
structure may affect the process of initiation of reverse
transcription. Although binding of the tRNA3Lys primer
onto the genomic RNA occurs at the primer-binding site that is located
downstream of TAR, additional interactions between the tRNA primer and
upstream viral RNA sequences have been proposed (1, 11, 36, 39,
58). In fact, there is some evidence from in vitro studies that
deletions within 5' R reduce the initiation of reverse transcription
(3). Alternatively, the TAR hairpin in the RNA template may
influence the process of elongation or the first strand transfer
reaction. Finally, because it has been reported that the Tat protein
can also stimulate reverse transcription (31), the role of
TAR may be to tether Tat to the RT enzyme.
Thus, a pleiotropy of functions have been attributed to the TAR motif
in a variety of experimental systems. The biologically most relevant
assay system is that of the replicating virus, and the importance of
TAR is underlined by the observation that mutations within TAR cause
severe replication defects (29, 42, 49). However, this
experimental system does not allow one to selectively study one of the
two TAR motifs that are present at the extreme 5' and 3' ends of the
viral genome. In particular, mutations introduced in 5' TAR will be
inherited in a dominant manner in both R regions (43).
Likewise, 3' TAR mutations will be lost after a single replication
cycle. To gain a better understanding of the role(s) of the 5'
and 3' TAR motifs, we examined transcription, translation, packaging, and reverse transcription properties of HIV-1 mutants with a
mutated 5' and/or 3' TAR structure in single-cycle assays. Because
replication of TAR-mutated viruses can be restored by the acquisition
of additional nucleotide substitutions that restore base pairing of the
TAR stem (30, 42), we also included such a revertant genome
in this study.
 |
MATERIALS AND METHODS |
Cells and viruses.
SupT1 and C8166 T cells were grown in
RPMI 1640 medium containing 10% fetal calf serum at 37°C and 5%
CO2. Cells were split 1 in 10 twice a week. C33A cervix
carcinoma cells (ATCC HTB31) (5) were grown as a monolayer
in Dulbecco's modified Eagle's medium supplemented with 10% fetal
calf serum and modified Eagle's medium nonessential amino acids at
37°C and 5% CO2. C33A cells were transfected by the
calcium phosphate method. Cells were grown to 60% confluence in
24-well multidish plates or 75-cm2 tissue culture flasks.
For transfection of the 24-well plates, 1 µg of DNA in 22 µl of
water was mixed with 25 µl of 2× HBS (50 mM HEPES [pH 7.1], 250 mM
NaCl, 1.5 mM Na2HPO4) and 3 µl of 2 M
CaCl2. For transfection of 75-cm2 flasks, 40 µg of DNA in 880 µl of water was mixed with 1 ml of 2× HBS and 120 µl of 2 M CaCl2. The mixtures were incubated at room
temperature for 20 min and subsequently added to the culture medium.
The culture medium was changed after 16 h. The full-length molecular HIV-1 clone pLAI (48) was used to produce
wild-type and mutant viruses. The construction of the 5' and 3' Xho+10
TAR mutation and selection of the revertant virus were described
previously (42).
Isolation of virion and intracellular HIV-1 RNA.
C33A cells
were transfected with the proviral clones. At 2 or 3 days after
transfection, the medium was centrifuged at 2,750 × g for 5 min. Virion RNA was isolated from 300 µl of the virus-containing supernatant by incubation with 500 µg of proteinase K per ml in the
presence of 1% sodium dodecyl sulfate (SDS) and 2.5 mM EDTA at 37°C
for 30 min and extracted twice with phenol-chloroform-isoamyl alcohol
(25:24:1). After addition of 10 µg of glycogen, the RNA was
precipitated with 0.3 M Na-acetate (pH 5.2) and 70% ethanol at
20°C, centrifuged at 16,000 × g for 20 min, washed
with 70% ethanol, and dried. The RNA was resuspended in 10 mM Tris-HCl (pH 7.5)-50 mM NaCl-10 mM MgCl2-1 mM dithiothreitol and
incubated with 10 U of DNase I (RNase free; Boehringer Mannheim) per
100 µl at 37°C for 30 min to remove any contaminating DNA. After
extraction with phenol-chloroform-isoamyl alcohol (25:24:1), the RNA
was precipitated with 0.3 M Na-acetate and 70% ethanol. The RNA was pelleted at 16,000 × g for 20 min, washed with 70%
ethanol, and dried. Pellets were resuspended in water and stored at
20°C.
Two days after transfection of C33A cells, total cellular RNA was
isolated by the acid guanidinium thiocyanate-phenol-chloroform method
(19). The RNA was incubated with DNase I (RNase free) and
extracted with phenol-chloroform-isoamyl-alcohol (25:24:1) as described
above for the virion RNA.
Quantification of viral RNA.
Virion and intracellular RNA
was spotted onto nitrocellulose membranes (BA-S 85; Schleicher and
Schuell) with a slot blot manifold and hybridized with a
32P-labeled HIV-1 gag-pol probe
(PvuII fragment of pLAI, positions +691 to +2881, which is
specific for unspliced HIV-1 RNA), as previously described
(24). Hybridization signals were quantitated with a
PhosphorImager (Molecular Dynamics). To verify the absence of
contaminating DNA, RNA was incubated with 0.5 N NaOH at 55°C for 30 min prior to slot blotting. This resulted in a complete loss of the
hybridization signals, indicating that the observed hybridization
signals correspond exclusively to genomic RNA.
CA p24 levels.
Culture supernatant was heat inactivated (30 min at 56°C) in the presence of 0.05% Empigen-BB (Calbiochem, La
Jolla, Calif.). The CA p24 concentration was determined by twin-site
enzyme-linked immunosorbent assay (ELISA), as described previously
(6).
Reverse transcription analysis upon infection of T cells.
Virus stocks were prepared by transfection of C33A cells. Three days
after transfection, the culture medium (20 ml) was centrifuged at 2,750 × g for 30 min to remove cells. The virus-containing supernatant was subsequently filtered through a 0.45-µm-pore-size filter (Schleicher and Schuell) and stored at
70°C. Contaminating plasmid DNA used for transfection was digested by incubation with 100 U
of DNase I (RNase free; Boehringer Mannheim) per ml and 10 mM
MgCl2 at 37°C for 1 h. SupT1 or C8166 cells
(8 × 106 in 5 ml of medium) were infected with the same
amount of wild-type and mutant virus (250 ng of CA p24) for 1 h at
37°C. A control sample was placed on ice to block the infection (0-h
sample). Viruses were removed from the cells by extensive washing. The cells were either harvested directly (1-h sample) or cultured for 2, 3, 4, and 20 h. Cells were pelleted by centrifugation at 2,750 × g for 4 min and washed with phosphate-buffered saline (10 mM
Na-phosphate [pH 7.4], 150 mM NaCl). DNA was solubilized by
resuspension of the cells in 10 mM Tris-HCl (pH 8.0)-1 mM EDTA-0.5% Tween 20. The sample was then incubated with 200 µg of proteinase K
per ml at 56°C for 30 min and at 95°C for 10 min. Early reverse transcription products formed after the first strand transfer were
amplified by PCR with a 5' primer identical to nef sequences (NEF-B/X; positions 8601 to 8621) and a 3' primer complementary to U5
sequences (CN1; positions 123 to 151). Late cDNA products were
amplified by PCR with a 5' primer identical to tat sequences (KV1; positions 5367 to 5385) and a 3' primer complementary to env sequences (WS3; positions 6125 to 6144). PCR products
were analyzed by agarose gel electrophoresis and Southern blotted onto a nylon membrane (Zeta probe; Bio-Rad). To quantitate the PCR products,
the filters were hybridized with 32P-labeled HIV-1 probes.
The filter with early PCR products was treated with an HIV-1 LTR probe
(positions
454 to +381). The blot with late PCR signals was probed
with an HIV-1 DNA fragment (positions 5821 to 6379), which was obtained
by ClaI-Asp718 digestion of pcDNA3-Tat
(55). Hybridization was performed in 0.5 M Na-phosphate (pH
7.2)-7% SDS-1 mM EDTA-50 µg of salmon testis DNA per ml at 65°C
for 16 h. Membranes were washed in 40 mM Na-phosphate (pH 7.2)-1% SDS at 65°C, three times for 5 min and once for 15 min, and
for 5 min in the same buffer without SDS at room temperature. Hybridization signals were quantitated with a PhosphorImager (Molecular Dynamics).
Reverse transcription on virion-extracted RNA genomes.
The
virion RNA was isolated by proteinase K treatment and phenol extraction
as described previously (23). Reverse transcription was
initiated from the associated tRNA primer or from a DNA oligonucleotide primer, which was first annealed to the HIV-1 RNA. This C(N1) primer is
complementary to nucleotides +123 to +151 of the viral RNA. Both the
oligonucleotide and tRNA primer extension assays were described
previously in detail (23).
 |
RESULTS |
Mutant and revertant TAR hairpins.
The 57 nucleotides at the
5' end of the HIV-1 repeat region can fold the relatively stable TAR
hairpin (Fig. 1). The lower TAR stem was
opened in the Xho+10 mutant by substituting nucleotides +3 to +16 for
an unrelated sequence with an XhoI restriction site (Fig.
1). This mutation was previously demonstrated to cause a severe virus
replication defect (42). Long-term culturing of this virus
resulted in the appearance of phenotypic revertants in which the base
pairing of the lower TAR stem was restored by acquisition of additional
mutations (Fig. 1). To characterize the replication defect of the
Xho+10 virus, proviral plasmids were constructed in which the mutant
TAR sequence was introduced into the 5' LTR (5' TAR mutant), the 3' LTR
(3' TAR mutant), or in both LTRs (5' + 3' TAR double mutant).
Furthermore, the revertant TAR sequence was introduced into the 5' LTR
of this double mutant. Thus, this revertant provirus contains a
repaired 5' TAR hairpin and a destabilized 3' TAR structure.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 1.
HIV-1 genomes with 5' and 3' TAR mutations. The upper
schematic shows HIV-1 genomic RNA with a tandem hairpin motif encoded
by the R region. The upstream hairpin is TAR (shaded); the downstream
structure is the poly(A) hairpin motif (24). RNA
secondary-structure predictions for the wild-type, Xho+10 mutant, and
revertant TAR elements are shown below. The free energy for each
structure was calculated with the Zuker algorithm (61) and
is given in kilocalories per mole. The mutated region of TAR is shaded,
and additional mutations in the revertant are boxed. Nucleotide numbers
are relative to the RNA start site at +1.
|
|
Destabilization of the 5' TAR structure results in a reduced
intracellular HIV-1 RNA level.
The wild-type and mutant proviruses
were transfected into C33A cells (human cervix carcinoma cells not
expressing the CD4 receptor), resulting in the synthesis of viral RNAs
and proteins and the production of infectious virions. Intracellular
RNA was isolated 2 days after transfection, and the level of unspliced HIV-1 RNA was determined by dot blot analysis (Fig.
2A). The intracellular HIV-1 RNA level
measured for the wild-type construct was set at 100%. The RNA
levels of the 5' TAR mutant and the 5' + 3' TAR double mutant
were reduced by approximately 50%, but a wild-type RNA level was
measured for the 3' TAR mutant. Apparently, destabilization of the 5'
TAR hairpin reduces the intracellular HIV-1 RNA content. Repair of the
5' TAR structure by introduction of the revertant sequence did almost
completely restore the RNA level to that of the wild-type construct.
These results are in agreement with previous observations and suggest a
critical role for the full-length TAR hairpin in optimal Tat-activated
LTR transcription (56).

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 2.
Analysis of wild-type, mutant, and revertant TAR
constructs. C33A cells were transfected with the proviral constructs,
and the intracellular HIV-1 RNA was quantitated by dot blot analysis
(A). Virus production was measured in the culture supernatant by CA p24
ELISA (B). These values were used to calculate translational efficiency
(C). Virion RNA levels were measured and compared either with the CA
p24 values (D) or with the intracellular HIV-1 RNA levels (E). The
former value represents the virion RNA content; the latter value
represents the RNA packaging efficiency. All parameters were
arbitrarily set at 100% for the wild-type HIV-1 construct. Standard
errors were calculated for independent transfections (except for the
TAR revertant in some panels). For panels C, D, and E, we first
calculated the ratio per independent experiment and next calculated the
mean value and standard error. wt, wild-type construct; 5', 5' TAR
mutant, 3', 3' TAR mutant; 5' + 3', 5' + 3' TAR double mutant; rev,
revertant construct (see the text).
|
|
Destabilization of 5' TAR enhances the translational
efficiency.
The production of viral proteins was assayed by
measuring the CA p24 level in the culture supernatant (Fig. 2B). This
level is similar for the wild-type, mutant, and revertant viruses.
These results were confirmed by Western blot analysis of intracellular HIV-1 proteins (not shown). To determine the translational efficiency of the corresponding mRNAs, the CA p24 values were compared with the
intracellular HIV-1 RNA levels, which were reduced for the 5' and
5' + 3' TAR mutants (Fig. 2A). The translational efficiency, expressed as the protein-to-RNA ratio (Fig. 2C), was increased approximately twofold for the two constructs with a destabilized 5' TAR
hairpin. These results are consistent with the idea that the wild-type
5' TAR hairpin is moderately inhibitory in the process of mRNA
translation (47). This partial translational block is relieved by destabilization of the 5' RNA structure and restored in the
5' revertant mRNA. No effect of the 3' TAR element on the translational
efficiency of HIV-1 mRNAs was measured.
Both 5' and 3' TAR hairpins contribute to RNA packaging.
We
next studied the effect of the 5' and 3' TAR mutations on packaging of
HIV-1 genomic RNA into virions. We therefore measured the virion RNA
level by dot blot analysis and calculated the relative RNA content of
the virions (virion RNA-to-CA p24 ratio; Fig. 2D). The virion RNA
content was reduced significantly for the mutant with an opened 5' TAR
hairpin. A small defect was measured for the 3' TAR-mutated virus, and
the 5' + 3' TAR double mutant was affected most severely. This defect
was largely restored in the revertant construct that has a repaired 5'
TAR motif.
However, because destabilization of the 5' TAR structure did also
affect the intracellular HIV-1 RNA level (Fig.
2A), the
virion
RNA-to-CA p24 ratio (Fig.
2D) may not accurately reflect
the RNA
packaging efficiency. As a more appropriate measure of
the packaging
efficiency, we therefore calculated the ratio of
virion RNA to
intracellular HIV-1 RNA (Fig.
2E). This packaging
efficiency was
reduced in both the 5' and the 3' TAR mutants to
70% of the wild-type
packaging efficiency, and only 40% packaging
was calculated for the
5' + 3' TAR double mutant. Upon introduction
of a revertant hairpin
at the 5' position in this double mutant,
the packaging ratio was found
to increase to the level of the
two constructs with a single mutant TAR
element. These results
show that both the 5' and the 3' TAR hairpins
contribute to RNA
packaging and that destabilization of either one of
these hairpins
reduces the packaging efficiency by approximately 30%.
TAR mutations do not affect the stability of virion RNA.
The
TAR hairpin is present at both the 5' and the 3' ends of the RNA
genome. Because this structure may protect the RNA molecule from
degradation by exonucleases, one could argue that the reduced packaging
efficiency measured for mutants with an opened 5' or 3' TAR structure
does in fact reflect reduced stability of the virion RNA
(51). We performed an additional experiment to test the
stability of virion RNA. The wild-type, double-mutant, and revertant
proviral constructs were transfected into C33A cells, and virions
produced between 48 and 64 h posttransfection were harvested. The
RNA content of these virions was determined either directly (0-h
sample) or after an additional 24-h incubation of the cell-free virions
at 37°C (Fig. 3). As observed
previously (Fig. 2E), the RNA level of the freshly made virions was
reduced for the 5' + 3' TAR mutant and restored in the revertant. The three viruses showed similar, approximately 2.5-fold drops in RNA
content following the 24-h incubation, indicating that the presence of
a truncated TAR stem at either end of HIV-1 RNA does not affect the
intravirion genome stability.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Stability of TAR-mutated RNA within virions. Wild-type,
mutant (5' + 3' TAR), and revertant constructs were used to produce
virions in transfected C33A cells. Virus particles produced between 48 and 64 h after transfection were harvested, and RNA was
quantitated either directly (0-h sample) or after incubation of the
virions for 24 h at 37°C in RPMI medium. The data are absolute
PhosphorImager counts divided by the CA p24 levels.
|
|
TAR hairpin mutations do not affect reverse transcription.
We
analyzed the effect of the TAR hairpin mutations on the process of
reverse transcription in infected cells. This assay was performed only
with the 5' + 3' TAR double mutant because all other mutants have
nonidentical 5' and 3' R regions, which will cause problems in the
first strand transfer step (13). Equal amounts of wild-type
and 5' + 3' TAR mutant viruses were used to infect the SupT1 and
C8166 T-cell lines. Viruses were incubated with the cells for 1 h
at 37°C and then removed by extensive washing. Cells were cultured
for a prolonged period. Control cells were harvested before the 37°C
incubation (0-h sample); the other samples were taken at 1, 2, 3, 4, or
20 h after infection. Total cellular DNA was extracted, and
reverse-transcribed HIV-1 DNA was PCR amplified with different primer
sets. Early reverse transcription products formed after the first
strand transfer were amplified with the 5' nef and 3' U5
primers, and cDNA products formed after continued reverse transcription
were detected with the 5' tat and 3' env primers.
These early and late cDNA products were analyzed by Southern blotting
(Fig. 4) and quantitated by
PhosphorImager analysis (Fig. 5). Early
cDNAs were detected as early as 1 h after infection of SupT1 cells
with either the wild-type or mutant virus. This early signal increased
in abundance over the next 3 h (Fig. 4A and 5A). At all times, a
reduced cDNA level was measured for the 5' + 3' TAR double mutant.
Similar results were obtained in the analysis of late cDNA products,
which were first detected 2 h after infection of SupT1 cells (Fig.
4B and 5B), and in the infection of C8166 cells (Fig. 4C and 5C). This
kinetic analysis of the reverse transcription reaction revealed a
significant reduction of cDNA products for the TAR-mutated virus
compared with the wild-type virus. However, this reduced cDNA level
correlated with the reduced RNA content of the mutant virus particles
(Fig. 2D). These results suggest that the efficiency of reverse
transcription is not significantly affected by the 5' + 3' TAR
mutations.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 4.
Reverse transcription of TAR-mutated viral transcripts
in infected cells. Wild-type and 5' + 3' TAR mutant virus stocks
(normalized by CA p24 levels) were used to infect SupT1 cells (A and B)
or C8166 cells (C). Cell samples were harvested at the times indicated.
Total cellular DNA was extracted, and HIV-1 cDNA was PCR amplified with
primers that detect early or late DNA products of reverse
transcription. PCR products were visualized on a Southern blot probed
with a 32P-labeled HIV-1 fragment. Hybridization signals
were quantitated with a PhosphorImager and are presented in Fig. 5. The
same PCR protocol was performed on various amounts of the pLAI HIV-1
plasmid to check that the amplification was performed within the linear
range.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 5.
Normal reverse transcription efficiency of TAR-mutated
viral transcripts. See the legend to Fig. 4 for details.
|
|
To further confirm these results, we performed reverse transcription
assays with the wild-type and mutant HIV-1 RNA genomes
that were
extracted from virion particles. The same amount of
virions (based on
CA p24) was used for this RNA isolation. In
a primer extension reaction
with a DNA oligonucleotide primer
complementary to the HIV-1 leader RNA
(Fig.
6), a reduced level
of the cDNA
product was obtained for the 5' + 3' TAR mutant (32%
of the
wild-type level). This reduced cDNA production correlates
precisely
with, and thus confirms, the reduced RNA content of
the mutant virus as
plotted in Fig.
2D. We also performed reverse
transcription in
the absence of an exogenous DNA primer. In this
case, a relatively weak
extension product, primed by the natural
tRNA
3Lys
primer that is coextracted with the virion RNA genome, can be
detected
(Fig.
6). The tRNA-primed cDNA signal obtained for the
mutant genome
was 27% compared with the wild-type signal. Given
the similar
reduction in RNA content, we conclude that there is
no significant
effect of the TAR mutations on the tRNA-primed
reverse transcription
reaction.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 6.
In vitro reverse transcription assays with the
TAR-mutated transcript. The RNA genomes of the wild-type and 5' + 3'
TAR mutant virus stocks (normalized by CA p24 levels) were phenol
extracted and analyzed in vitro. Reverse transcription from the
associated tRNA3Lys primer was initiated by addition of
RT and deoxynucleoside triphosphates. In the oligonucleotide-primed
reaction, an exogenous DNA-oligonucleotide primer was annealed to the
virion RNA and extended by reverse transcription. The
oligonucleotide-primed and tRNA extension signals were analyzed with a
PhosphorImager, and their profiles are shown below. The relative level
of cDNA production was set at 100% for the wild-type template in both
primer extension assays.
|
|
 |
DISCUSSION |
Our data indicate that the structured TAR RNA motif plays several
roles in the HIV-1 replication cycle. Besides the well-known transcriptional function of the 5' TAR hairpin, this motif was found to
partially repress translation of the viral RNA and to stimulate
packaging of the RNA genome. The 3' TAR motif also activated the
encapsidation of RNA into virions, and this contribution to packaging
was quantitatively similar to that of the 5' TAR element. Reduced
reverse transcription levels were demonstrated to correlate with the
reduced level of RNA template within the mutant virions. Although all
reported TAR effects seem to depend on the base-paired structure of
this RNA signal, it cannot be excluded that important nucleotide
sequences within TAR are also critical for some of these functions.
However, the finding that the TAR functions can be restored by the
additional nucleotide changes observed in a revertant TAR element with
a repaired stem suggests that the actual sequence of the lower TAR stem
is not important for these functions.
We observed that mutant HIV-1 mRNAs with a destabilized 5' TAR
structure can be translated more efficiently than the wild-type transcript. This indicates that there is a repressive effect of the
wild-type TAR hairpin, which is consistent with previous reports (26, 47, 50, 53, 57). The TAR effect may operate either in
cis by restricting the accessibility of the mRNA cap
structure to the translational machinery or in trans through
induction of the PKR protein kinase system. Whatever the mechanism, it
is possible that translational repression observed for wild-type HIV-1
RNA is a viral strategy to balance the processes of translation and packaging. This may provide the optimal amount of genomic RNA and viral
proteins, and therefore ultimately control the production of infectious
virus. Previous findings with murine leukemia virus suggested that
full-length viral RNA was routed to either a pool for translation or a
pool for packaging and that the RNA bound by ribosomes could not be
packaged (44). For Rous sarcoma virus, it has been reported
recently that this sorting mechanism is mediated by the viral Gag
proteins (54).
In this study, we measured reduced virion RNA levels with both 5' and
3' TAR mutants. Part of this reduction is directly due to the lower
levels of intracellular HIV-1 RNA, suggesting that the RNA packaging
efficiency is exquisitely sensitive to changes in the concentration of
intracellular RNA. Therefore, the ratio of virion RNA to intracellular
HIV-1 RNA (Fig. 2E) is a better measure of the packaging efficiency
than the ratio of virion RNA to virion protein (Fig. 2D). After
correction for the reduced amount of intracellular RNA, a packaging
defect remained for the mutants. The contribution of the 5' TAR motif
to packaging is consistent with a previous study (46), and
we now report a quantitatively similar contribution of the 3' TAR
element. With the results of other studies in mind (2, 20, 21, 33,
45), it is appropriate to consider the entire untranslated 5'
leader region as the packaging signal (8). It is likely that
the complete leader region is required to fold a specific tertiary RNA
structure that forms the actual packaging signal. It is also possible
that the TAR motif affects RNA dimerization (14, 34), which
in turn may affect the process of RNA packaging (27).
Therefore, the TAR motif will reflect the superimposed demands of
multiple essential processes, which could be difficult to separate
experimentally.
The finding that the 3' end of the viral genome also contributes to
packaging may suggest that both ends of the RNA interact, a phenomenon
that has been proposed for cellular transcripts to explain the effects
that the poly(A) tail and 3' untranslated region can have on
translation initiation (7, 37). There is no direct
biochemical evidence for such a 5'-to-3' interaction in HIV-1 RNA, but
the close proximity of the two R regions may be particularly
advantageous in the strand transfer step of reverse transcription. In
fact, there is some recent evidence that the native dimer conformation
of HIV-1 virion RNA is required for this strand transfer step
(9). Finally, the presence of multiple accessory packaging
signals in parts of the genome that are present in spliced HIV-1 RNAs
can explain the relative abundance of such subgenomic RNAs in
viral particles (45, 46).
Our results are not consistent with a previous report on the effect of
TAR on reverse transcription (32). It remains possible that
these conflicting results are caused by differences in the TAR
mutants used in the two studies. For instance, we analyzed TAR
mutants with an opened lower stem, whereas changes in the upper
TAR domain that forms the Tat binding site may be important for reverse
transcription. However, the previous study (32) reported
that the Tat-binding domain within TAR is dispensable for
TAR-mediated activation of reverse transcription. In fact, most
dramatic effects were observed with stem mutants, which are very
similar to the Xho+10 mutant used in this study. It is possible that
the level of HIV-1 RNA in the virion particles was not accurately measured in the former study (32). Specifically, an RT-PCR
protocol was used that does not discriminate between spliced and
unspliced HIV-1 mRNAs. Spliced HIV-1 RNAs are encapsidated with
high efficiency compared with nonviral RNA (15), and
mutants that package less full-length RNA genome seem to compensate
this defect by increased packaging of spliced HIV-1 RNAs
(52). Thus, the RT-PCR measure may have underestimated
the packaging defect of TAR-mutated transcripts. Indeed, whereas
we measured a virion RNA content of only 30% for the mutant with an
opened 5' and 3' TAR motif, no such packaging defect has been reported
for similar TAR mutants in the former study. We measured the reverse
transcription efficiency both in assays with infected cells and in in
vitro assays with the virion-extracted RNA genome. When the reduced
level of cDNA production was corrected for this diminished
concentration of RNA template, no net effect of TAR on reverse
transcription was measured. It has been reported that the viral Tat
protein may exert additional functions in the virus life cycle
(35), and a putative role in reverse transcription was
proposed (31). We did not address this issue in the current study, but some evidence was recently presented against a Tat function
other than its role in activated transcription from the viral LTR
promoter (40, 55).
 |
ACKNOWLEDGMENTS |
We thank Koen Verhoef for critical reading of the manuscript and
Wim van Est for photography.
This work was supported by grants from the Dutch Cancer Society (KWF),
the European Community (EU 950675), and the Dutch AIDS Fund.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Human Retrovirology, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. Phone:
31-20-5664854. Fax: 31-20-6916531. E-mail:
B.Berkhout{at}AMC.UVA.NL.
 |
REFERENCES |
| 1.
|
Aiyar, A.,
D. Cobrinik,
Z. Ge,
H. J. Kung, and J. Leis.
1992.
Interaction between retroviral U5 RNA and the TYC loop of the tRNATrp primer is required for efficient initiation of reverse transcription.
J. Virol.
66:2464-2472[Abstract/Free Full Text].
|
| 2.
|
Aldovini, A., and R. A. Young.
1990.
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging results in production of noninfectious virus.
J. Virol.
64:1920-1926[Abstract/Free Full Text].
|
| 3.
|
Arts, E. J.,
X. Li,
Z. Gu,
L. Kleiman,
M. A. Parniak, and M. A. Wainberg.
1994.
Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.
J. Biol. Chem.
269:14672-14680[Abstract/Free Full Text].
|
| 4.
|
Ashe, M. P.,
L. H. Pearson, and N. J. Proudfoot.
1997.
The HIV-1 5' LTR poly(A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site.
EMBO J.
16:5752-5763[Medline].
|
| 5.
|
Auersperg, N.
1964.
Long-term cultivation of hypodiploid human tumor cells.
J. Natl. Cancer Inst.
32:135-163.
|
| 6.
|
Back, N. K. T.,
M. Nijhuis,
W. Keulen,
C. A. B. Boucher,
B. B. Oude Essink,
A. B. P. van Kuilenburg,
A. H. Van Gennip, and B. Berkhout.
1996.
Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
EMBO J.
15:4040-4049[Medline].
|
| 7.
|
Beelman, C. A., and R. Parker.
1995.
Degradation of mRNA in eukaryotes.
Cell
81:179-183[Medline].
|
| 8.
|
Berkhout, B.
1996.
Structure and function of the human immunodeficiency virus leader RNA.
Prog. Nucleic Acid Res. Mol. Biol.
54:1-34[Medline].
|
| 9.
|
Berkhout, B.,
A. T. Das, and J. L. B. van Wamel.
1998.
The native structure of the HIV-1 RNA genome is required for the first strand-transfer of reverse transcription.
Virology
249:211-218[Medline].
|
| 10.
|
Berkhout, B.,
B. Klaver, and A. T. Das.
1995.
A conserved hairpin structure predicted for the poly(A) signal of human and simian immunodeficiency viruses.
Virology
207:276-281[Medline].
|
| 11.
|
Berkhout, B., and I. Schoneveld.
1993.
Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site.
Nucleic Acids Res.
21:1171-1178[Abstract/Free Full Text].
|
| 12.
|
Berkhout, B.,
R. H. Silverman, and K. T. Jeang.
1989.
Tat trans-activates the human immunodeficiency virus through a nascent RNA target.
Cell
59:273-282[Medline].
|
| 13.
|
Berkhout, B.,
J. van Wamel, and B. Klaver.
1995.
Requirements for DNA strand transfer during reverse transcription in mutant HIV-1 virions.
J. Mol. Biol.
252:59-69[Medline].
|
| 14.
|
Berkhout, B., and J. L. B. van Wamel.
1996.
Role of the DIS hairpin in replication of human immunodeficiency virus type 1.
J. Virol.
70:6723-6732[Abstract/Free Full Text].
|
| 15.
|
Berkowitz, R. D.,
A. Ohagen,
S. Hoglund, and S. P. Goff.
1995.
Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.
J. Virol.
69:6445-6456[Abstract].
|
| 16.
|
Braddock, M.,
R. Powell,
A. D. Blanchard,
A. J. Kingsman, and S. M. Kingsman.
1993.
HIV-1 TAR RNA-binding proteins control TAT activation of translation in Xenopus oocytes.
FASEB J.
7:214-222[Abstract].
|
| 17.
|
Braddock, M.,
A. M. Thorburn,
A. Chambers,
G. D. Elliot,
G. J. Anderson,
A. J. Kingsman, and S. M. Kingsman.
1990.
A nuclear translational block imposed by the HIV-1 U3 region is relieved by the Tat-TAR interaction.
Cell
62:1123-1133[Medline].
|
| 18.
|
Brown, P. H.,
L. S. Tiley, and B. R. Cullen.
1991.
Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences.
J. Virol.
65:3340-3343[Abstract/Free Full Text].
|
| 19.
|
Chomczynski, P., and N. Sacchi.
1987.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal. Biochem.
162:156-159[Medline].
|
| 20.
|
Clavel, F., and J. M. Orenstein.
1990.
A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.
J. Virol.
64:5230-5234[Abstract/Free Full Text].
|
| 21.
|
Clever, J.,
C. Sassetti, and T. G. Parslow.
1995.
RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.
J. Virol.
69:2101-2109[Abstract].
|
| 22.
|
Cullen, B. R.
1986.
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism.
Cell
46:973-982[Medline].
|
| 23.
|
Das, A. T.,
B. Klaver, and B. Berkhout.
1995.
Reduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA3Lys.
J. Virol.
69:3090-3097[Abstract].
|
| 24.
|
Das, A. T.,
B. Klaver,
B. I. F. Klasens,
J. L. B. van Wamel, and B. Berkhout.
1997.
A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication.
J. Virol.
71:2346-2356[Abstract].
|
| 25.
|
Dingwall, C.,
I. Ernberg,
M. J. Gait,
S. M. Green,
S. Heaphy,
J. Karn,
A. D. Lowe,
M. Singh,
M. A. Skinner, and R. Valerio.
1989.
Human immunodeficiency virus 1 tat protein binds trans-activating-responsive region (TAR) RNA in vitro.
Proc. Natl. Acad. Sci. USA
86:6925-6929[Abstract/Free Full Text].
|
| 26.
|
Edery, I. R.,
R. Petryshyn, and N. Sonenberg.
1989.
Activation of double-stranded RNA dependent kinase (dsI) by the TAR region of HIV-1 mRNA: a novel translational control mechanism.
Cell
56:303-312[Medline].
|
| 27.
|
Fu, W.,
R. J. Gorelick, and A. Rein.
1994.
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.
J. Virol.
68:5013-5018[Abstract/Free Full Text].
|
| 28.
|
Gilmartin, G. M.,
E. S. Fleming,
J. Oetjen, and B. R. Graveley.
1995.
CPSF recognition of an HIV-1 mRNA 3'-processing enhancer: multiple sequence contacts involved in poly(A) site definition.
Genes Dev.
9:72-83[Abstract/Free Full Text].
|
| 29.
|
Harrich, D.,
C. Hsu,
E. Race, and R. B. Gaynor.
1994.
Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants.
J. Virol.
68:5899-5910[Abstract/Free Full Text].
|
| 30.
|
Harrich, D.,
G. Mavankal,
A. Mette-Snider, and R. B. Gaynor.
1995.
Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication.
J. Virol.
69:4906-4913[Abstract].
|
| 31.
|
Harrich, D.,
C. Ulich,
L. F. Garcia-Martinez, and R. B. Gaynor.
1997.
Tat is required for efficient HIV-1 reverse transcription.
EMBO J.
16:1224-1235[Medline].
|
| 32.
|
Harrich, D.,
C. Ulich, and R. B. Gaynor.
1996.
A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription.
J. Virol.
70:4017-4027[Abstract].
|
| 33.
|
Harrison, G. P., and A. M. L. Lever.
1992.
The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.
J. Virol.
66:4144-4153[Abstract/Free Full Text].
|
| 34.
|
Hoglund, S.,
A. Ohagen,
J. Goncalves,
A. T. Panganiban, and D. Gabuzda.
1997.
Ultrastructure of HIV-1 genomic RNA.
Virology
233:271-279[Medline].
|
| 35.
|
Huang, L. M.,
A. Joshi,
R. Willey,
J. Orenstein, and K. T. Jeang.
1994.
Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity.
EMBO J.
13:2886-2896[Medline].
|
| 36.
|
Isel, C.,
C. Ehresmann,
G. Keith,
B. Ehresmann, and R. Marquet.
1995.
Initiation of reverse transcription of HIV-1: secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer).
J. Mol. Biol.
247:236-250[Medline].
|
| 37.
|
Jackson, R. J., and N. Standart.
1990.
Do the poly(A) tail and 3' untranslated region control mRNA translation?
Cell
62:15-24[Medline].
|
| 38.
|
Jeang, K. T.,
R. Chun,
N. H. Lin,
A. Gatignol,
C. G. Glabe, and H. Fan.
1993.
In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor.
J. Virol.
67:6224-6233[Abstract/Free Full Text].
|
| 39.
|
Kang, S.-M.,
J. K. Wakefield, and C. D. Morrow.
1996.
Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription.
Virology
222:401-414[Medline].
|
| 40.
|
Kim, V. N.,
K. Mitrophanous,
S. M. Kingsman, and A. J. Kingsman.
1998.
Minimal requirements for a lentivirus vector based on human immunodeficiency virus type 1.
J. Virol.
72:811-816[Abstract/Free Full Text].
|
| 41.
|
Klaver, B., and B. Berkhout.
1994.
Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus.
J. Virol.
68:3830-3840[Abstract/Free Full Text].
|
| 42.
|
Klaver, B., and B. Berkhout.
1994.
Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus.
EMBO J.
13:2650-2659[Medline].
|
| 43.
|
Klaver, B., and B. Berkhout.
1994.
Premature strand transfer by the HIV-1 reverse transcriptase during strong-stop DNA synthesis.
Nucleic Acids Res.
22:137-144[Abstract/Free Full Text].
|
| 44.
|
Levin, J. G., and M. J. Rosenak.
1976.
Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin-D-treated cells: evidence for persistence of viral messenger RNA.
Proc. Natl. Acad. Sci. USA
73:1154-1158[Abstract/Free Full Text].
|
| 45.
|
McBride, M. S., and A. T. Panganiban.
1996.
The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures.
J. Virol.
70:2963-2973[Abstract].
|
| 46.
|
McBride, M. S.,
M. D. Schwartz, and A. T. Panganiban.
1997.
Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.
J. Virol.
71:4544-4554[Abstract].
|
| 47.
|
Parkin, N. T.,
E. A. Cohen,
A. Darveau,
C. Rosen,
W. Haseltine, and N. Sonenberg.
1988.
Mutational analysis of the 5' noncoding region of human immunodeficiency virus type 1: effects of secondary structure.
EMBO J.
7:2831-2837[Medline].
|
| 48.
|
Peden, K.,
M. Emerman, and L. Montagnier.
1991.
Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.
Virology
185:661-672[Medline].
|
| 49.
|
Rounseville, M. P.,
H. C. Lin,
E. Agbottah,
R. R. Shukla,
A. B. Rabson, and A. Kumar.
1996.
Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
Virology
216:411-417[Medline].
|
| 50.
|
Roy, S.,
M. Agy,
A. G. Hovanessian,
N. Sonenberg, and M. G. Katze.
1991.
The integrity of the stem structure of human immunodeficiency virus type 1 Tat-responsive sequence of RNA is required for interaction with the interferon-induced 68,000-Mr protein kinase.
J. Virol.
65:632-640[Abstract/Free Full Text].
|
| 51.
|
Sakuragi, J.-I., and A. T. Panganiban.
1997.
Human immunodeficiency virus type 1 RNA outside the primary encapsidation and dimer linkage region affects RNA dimer stability in vivo.
J. Virol.
71:3250-3254[Abstract].
|
| 52.
|
Schwartz, M. D.,
D. Fiore, and A. T. Panganiban.
1997.
Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication.
J. Virol.
71:9295-9305[Abstract].
|
| 53.
|
SenGupta, D. N.,
B. Berkhout,
A. Gatignol,
A. M. Zhou, and R. H. Silverman.
1990.
Direct evidence for translational regulation by leader RNA and Tat protein of human immunodeficiency virus type 1.
Proc. Natl. Acad. Sci. USA
87:7492-7496[Abstract/Free Full Text].
|
| 54.
|
Sonstegard, T. S., and P. B. Hackett.
1996.
Autogenous regulation of RNA translation and packaging by Rous sarcoma virus Pr76gag.
J. Virol.
70:6642-6652[Abstract/Free Full Text].
|
| 55.
|
Verhoef, K.,
M. Koper, and B. Berkhout.
1997.
Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication.
Virology
237:228-236[Medline].
|
| 56.
|
Verhoef, K.,
M. Tijms, and B. Berkhout.
1997.
Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
Nucleic Acids Res.
25:496-502[Abstract/Free Full Text].
|
| 57.
|
Viglianti, G. A.,
E. C. Rubinstein, and K. L. Graves.
1992.
Role of the TAR RNA splicing in translational regulation of simian immunodeficiency virus from rhesus macaques.
J. Virol.
66:4824-4833[Abstract/Free Full Text].
|
| 58.
|
Wakefield, J. K.,
S.-M. Kang, and C. D. Morrow.
1996.
Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNAHis.
J. Virol.
70:966-975[Abstract].
|
| 59.
|
Wu-Baer, F.,
W. S. Lane, and R. B. Gaynor.
1996.
Identification of a group of cellular cofactors that stimulate the binding of RNA polymerase II and TRP-185 to human immunodeficiency virus 1 TAR RNA.
J. Biol. Chem.
271:4201-4208[Abstract/Free Full Text].
|
| 60.
|
Wu-Baer, F.,
D. Sigman, and R. B. Gaynor.
1995.
Specific binding of RNA polymerase II to the human immunodeficiency virus trans-activating region RNA is regulated by cellular cofactors and Tat.
Proc. Natl. Acad. Sci. USA
92:7153-7157[Abstract/Free Full Text].
|
| 61.
|
Zuker, M.
1989.
On finding all suboptimal foldings of an RNA molecule.
Science
244:48-52[Abstract/Free Full Text].
|
Journal of Virology, November 1998, p. 9217-9223, Vol. 72, No. 11
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vrolijk, M. M., Ooms, M., Harwig, A., Das, A. T., Berkhout, B.
(2008). Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA. Nucleic Acids Res
36: 4352-4363
[Abstract]
[Full Text]
-
Laham-Karam, N., Bacharach, E.
(2007). Transduction of Human Immunodeficiency Virus Type 1 Vectors Lacking Encapsidation and Dimerization Signals. J. Virol.
81: 10687-10698
[Abstract]
[Full Text]
-
Houzet, L., Paillart, J. C., Smagulova, F., Maurel, S., Morichaud, Z., Marquet, R., Mougel, M.
(2007). HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms. Nucleic Acids Res
0: gkm153v1-10
[Abstract]
[Full Text]
-
Song, M., Balakrishnan, M., Chen, Y., Roques, B. P., Bambara, R. A.
(2006). Stimulation of HIV-1 Minus Strand Strong Stop DNA Transfer by Genomic Sequences 3' of the Primer Binding Site. J. Biol. Chem.
281: 24227-24235
[Abstract]
[Full Text]
-
Brandt, S., Grunwald, T., Lucke, S., Stang, A., Uberla, K.
(2006). Functional replacement of the R region of simian immunodeficiency virus-based vectors by heterologous elements.. J. Gen. Virol.
87: 2297-2307
[Abstract]
[Full Text]
-
Das, A. T., Vink, M., Berkhout, B.
(2005). Alternative tRNA Priming of Human Immunodeficiency Virus Type 1 Reverse Transcription Explains Sequence Variation in the Primer-Binding Site That Has Been Attributed to APOBEC3G Activity. J. Virol.
79: 3179-3181
[Abstract]
[Full Text]
-
Ooms, M., Huthoff, H., Russell, R., Liang, C., Berkhout, B.
(2004). A Riboswitch Regulates RNA Dimerization and Packaging in Human Immunodeficiency Virus Type 1 Virions. J. Virol.
78: 10814-10819
[Abstract]
[Full Text]
-
Xie, B., Calabro, V., Wainberg, M. A., Frankel, A. D.
(2004). Selection of TAR RNA-Binding Chameleon Peptides by Using a Retroviral Replication System. J. Virol.
78: 1456-1463
[Abstract]
[Full Text]
-
Quinones-Mateu, M. E., Gao, Y., Ball, S. C., Marozsan, A. J., Abraha, A., Arts, E. J.
(2002). In Vitro Intersubtype Recombinants of Human Immunodeficiency Virus Type 1: Comparison to Recent and Circulating In Vivo Recombinant Forms. J. Virol.
76: 9600-9613
[Abstract]
[Full Text]
-
Paillart, J.-C., Skripkin, E., Ehresmann, B., Ehresmann, C., Marquet, R.
(2002). In Vitro Evidence for a Long Range Pseudoknot in the 5'-Untranslated and Matrix Coding Regions of HIV-1 Genomic RNA. J. Biol. Chem.
277: 5995-6004
[Abstract]
[Full Text]
-
Guan, Y., Diallo, K., Whitney, J. B., Liang, C., Wainberg, M. A.
(2001). An Intact U5-Leader Stem Is Important for Efficient Replication of Simian Immunodeficiency Virus. J. Virol.
75: 11924-11929
[Abstract]
[Full Text]
-
Rong, L., Russell, R. S., Hu, J., Guan, Y., Kleiman, L., Liang, C., Wainberg, M. A.
(2001). Hydrophobic Amino Acids in the Human Immunodeficiency Virus Type 1 p2 and Nucleocapsid Proteins Can Contribute to the Rescue of Deleted Viral RNA Packaging Signals. J. Virol.
75: 7230-7243
[Abstract]
[Full Text]
-
Huthoff, H., Berkhout, B.
(2001). Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA. Nucleic Acids Res
29: 2594-2600
[Abstract]
[Full Text]
-
Ohi, Y., Clever, J. L.
(2000). Sequences in the 5' and 3' R Elements of Human Immunodeficiency Virus Type 1 Critical for Efficient Reverse Transcription. J. Virol.
74: 8324-8334
[Abstract]
[Full Text]
-
Liang, C., Rong, L., Russell, R. S., Wainberg, M. A.
(2000). Deletion Mutagenesis Downstream of the 5' Long Terminal Repeat of Human Immunodeficiency Virus Type 1 Is Compensated for by Point Mutations in both the U5 Region and gag Gene. J. Virol.
74: 6251-6261
[Abstract]
[Full Text]
-
Harrich, D., Hooker, C. W., Parry, E.
(2000). The Human Immunodeficiency Virus Type 1 TAR RNA Upper Stem-Loop Plays Distinct Roles in Reverse Transcription and RNA Packaging. J. Virol.
74: 5639-5646
[Abstract]
[Full Text]
-
Cui, Y., Iwakuma, T., Chang, L.-J.
(1999). Contributions of Viral Splice Sites and cis-Regulatory Elements to Lentivirus Vector Function. J. Virol.
73: 6171-6176
[Abstract]
[Full Text]
-
Helga-Maria, C., Hammarskjöld, M.-L., Rekosh, D.
(1999). An Intact TAR Element and Cytoplasmic Localization Are Necessary for Efficient Packaging of Human Immunodeficiency Virus Type 1 Genomic RNA. J. Virol.
73: 4127-4135
[Abstract]
[Full Text]
-
Das, A. T., Klaver, B., Berkhout, B.
(1999). A Hairpin Structure in the R Region of the Human Immunodeficiency Virus Type 1 RNA Genome Is Instrumental in Polyadenylation Site Selection. J. Virol.
73: 81-91
[Abstract]
[Full Text]
-
Smith, S. M., Khoroshev, M., Marx, P. A., Orenstein, J., Jeang, K.-T.
(2001). Constitutively Dead, Conditionally Live HIV-1 Genomes. EX VIVO IMPLICATIONS FOR A LIVE VIRUS VACCINE. J. Biol. Chem.
276: 32184-32190
[Abstract]
[Full Text]